Cytotoxic T lymphocyte responses to vaccinia virus antigens but not HIV-1 subtype E envelope protein seen in HIV-1 seronegative Thais

Asian Pacific Journal of Allergy and Immunology

Volumn 19, Issue 1, 2001, Pages 17-22

  Kantakamalakul, W ^a   Cox, J ^a   Kositanont, U ^a   Siritantikorn, S ^a   Limbach, K ^a   Birx, D ^a   Thongcharoen, P ^a   Puthavathana, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALVAC HIV; GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEINASE; UNCLASSIFIED DRUG; VCP 1521; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; MALE; NONHUMAN; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; STIMULATION; THAILAND; VACCINATION; VACCINIA VIRUS;

ADULT; ANTIGENS, VIRAL; B-LYMPHOCYTES; FEMALE; HERPESVIRUS 4, HUMAN; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; THAILAND; VACCINIA VIRUS;

EID: 0034920984     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AIDS vaccine research in Asia: Needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998
2. Clinical disease associated with HIV-1 subtype B′ and E infection among 2,104 patients in Thailand
3. A canarypox vector expressing multiple human immunodeficiency virus type 1 genes given alone or in combination with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
4. A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans
5. Standardization of smallpox vaccines and the eradication programme - A WHO perspective
6. Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans
7. Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus
8. Human cytotoxic T cell responses to vaccinia virus vaccination
9. HIV-1 specific cytotoxic T cell assays
10. Induction of HIV-1 specific cytolytic responses in seronegative adults by a non-replicating, host range restricted canarypox vector (ALVAC) carrying the HIV-1 MN env gene
11. Specific activation strategies for amplification of low CTL signals
12. The prime-boost concept applied to HIV preventive vaccines
13. Canarypox virus-based vaccines: Primeboost strategies to induce cell-mediated and humoral immunity against HIV
14. HIV type-1 vaccine-induced cytotoxic T cell responses: Potential role in vaccine efficacy
15. Poxvirus pathogenesis
16. Aspects of cytotoxic T cell memory
17. Cytotoxic T-cell memory without antigen
18. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses
19. Protective heterologous antivaral immunity and enhanced immunopathogenesis mediated by memory T cell populations